about
Current systemic treatment of hepatocellular carcinoma: A review of the literatureAdvances in non-surgical management of primary liver cancer.Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma.Systemic treatment of hepatocellular carcinoma: Past, present and futureNew progress of non-surgical treatments for hepatocellular carcinoma.Portal vein thrombosis and arterioportal shunts: effects on tumor response after chemoembolization of hepatocellular carcinoma.Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview.Gene- and immunotherapy for hepatocellular carcinoma.Transarterial chemoembolization with/without cryotherapy is associated with improved clinical outcomes of sorafenib for the treatment of advanced hepatocellular carcinomaSystematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials.A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma.Hepatocellular carcinoma: management of an increasingly common problemMolecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib.Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma.Combined sorafenib and yttrium-90 radioembolization for the treatment of advanced hepatocellular carcinoma.Evolution of systemic therapy of advanced hepatocellular carcinoma.Managing patients receiving sorafenib for advanced hepatocellular carcinoma: a case study.Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor response.
P2860
Q27026036-14A81DF1-B39C-4169-B754-368E20DA08E3Q30423781-258CEA11-965F-4327-8C0B-1C5E1D0F3E77Q33747394-4C093486-BB95-4ECB-BFA1-955DBB83FB68Q33854034-D8C4B161-4C14-4C3C-8737-C40ED6449E90Q34647076-A6BA2BE6-5A48-4A71-A6D6-8955D7D4713BQ34744815-B343D07E-0B5E-4851-9A9F-EA16DFB00D76Q35541482-B89AC3FA-2F20-4BC7-9E85-431E268D17D0Q36150432-131006D6-5B03-4597-A17D-D4C204DE343BQ36285672-6E2BA494-D32A-42E8-8ED3-51D2A5A23273Q36476765-AF49F308-56E6-4D1D-8E5B-6865EE70808CQ36557480-76F93E11-DBA9-4036-ABF7-0A389DA178E8Q36746503-2202044A-2830-4FCF-AEEF-1031840E034CQ37779804-4FDA7AEE-80FA-4E6C-AB06-42084D748143Q39994567-A40FE423-C637-4EFF-A442-F9211A052C26Q41584458-EDDAE87B-A126-4B6A-BB87-DED2B332C212Q42617015-E68EFB04-0D75-4597-9677-DBB2989D2822Q42948849-B3374DDF-17CE-4022-BAD5-E7F7D21989B3Q46183882-C1887E12-CB9B-4CA1-B332-A25C22697B03
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Systemic therapies for hepatocellular carcinoma.
@ast
Systemic therapies for hepatocellular carcinoma.
@en
type
label
Systemic therapies for hepatocellular carcinoma.
@ast
Systemic therapies for hepatocellular carcinoma.
@en
prefLabel
Systemic therapies for hepatocellular carcinoma.
@ast
Systemic therapies for hepatocellular carcinoma.
@en
P2093
P2860
P1476
Systemic therapies for hepatocellular carcinoma.
@en
P2093
Daniel H Palmer
Philip J Johnson
Syed A Hussain
P2860
P304
P356
10.1517/13543784.13.12.1555
P407
P577
2004-12-01T00:00:00Z